These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1674916)

  • 1. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
    Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
    Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
    Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
    J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
    Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
    Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of [3H]CGP 39653 binding by glycine in rat brain.
    Mugnaini M; Giberti A; Ratti E; van Amsterdam FT
    J Neurochem; 1993 Oct; 61(4):1492-7. PubMed ID: 8104234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements.
    Grimwood S; Foster AC; Kemp JA
    Br J Pharmacol; 1991 Jun; 103(2):1385-92. PubMed ID: 1832067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
    Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
    Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
    Reynolds IJ
    J Neurochem; 1994 Jan; 62(1):54-62. PubMed ID: 7903355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]D-2-amino-5-phosphonopentanoate as a ligand for N-methyl-D-aspartate receptors in the mammalian central nervous system.
    Olverman HJ; Jones AW; Watkins JC
    Neuroscience; 1988 Jul; 26(1):1-15. PubMed ID: 2901689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization of rat brain phencyclidine receptors in an active binding form that is sensitive to N-methyl-D-aspartate receptor ligands.
    Ambar I; Kloog Y; Sokolovsky M
    J Neurochem; 1988 Jul; 51(1):133-40. PubMed ID: 2898002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the N-methyl-D-aspartate (NMDA) receptor recognition site in porcine cerebral cortical membranes using [3H]-CGP 39653.
    Banks MD; Sandberg MP; Fowler CJ
    Comp Biochem Physiol A Physiol; 1995 May; 111(1):39-46. PubMed ID: 7735908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity.
    Neijt H; Koller M; Urwyler S
    Biochem Pharmacol; 2001 Feb; 61(3):343-9. PubMed ID: 11172739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular target size analyses of the NMDA-receptor complex in rat cortex.
    Honoré T; Drejer J; Nielsen EO; Watkins JC; Olverman HJ; Nielsen M
    Eur J Pharmacol; 1989 Aug; 172(3):239-47. PubMed ID: 2550262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel.
    Franklin PH; Murray TF
    Mol Pharmacol; 1992 Jan; 41(1):134-46. PubMed ID: 1370704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between the glutamate and glycine recognition sites of the N-methyl-D-aspartate receptor from rat brain, as revealed from radioligand binding studies.
    Grimwood S; Wilde GJ; Foster AC
    J Neurochem; 1993 May; 60(5):1729-38. PubMed ID: 8097236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on binding of 3 different ligands to the N-methyl-D-aspartate recognition domain in brain synaptic membranes treated with Triton X-100.
    Zuo P; Ogita K; Han D; Yoneda Y
    Brain Res; 1993 Apr; 609(1-2):253-61. PubMed ID: 8099522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.